BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
-3.96%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$11.5B
AUM Growth
+$11.5B
Cap. Flow
+$415M
Cap. Flow %
3.6%
Top 10 Hldgs %
81.68%
Holding
129
New
8
Increased
22
Reduced
12
Closed
5

Top Buys

1
BMRN icon
BioMarin Pharmaceuticals
BMRN
$150M
2
ABLX
Ablynx NV American Depositary Shares
ABLX
$104M
3
PHXM
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$68M
4
RYTM icon
Rhythm Pharmaceuticals
RYTM
$59.5M
5
ARGX icon
argenx
ARGX
$54.4M

Top Sells

1
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
$179M
2
AKAO
Achaogen, Inc.
AKAO
$40.4M
3
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
$22.2M
4
EXEL icon
Exelixis
EXEL
$17.5M
5
LOXO
Loxo Oncology, Inc
LOXO
$8.85M

Sector Composition

1 Healthcare 93.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NKTR icon
51
Nektar Therapeutics
NKTR
$537M
$10.3M 0.09%
+171,934
New +$10.3M
LGND icon
52
Ligand Pharmaceuticals
LGND
$3.22B
$10M 0.09%
73,386
– –
STML
53
DELISTED
Stemline Therapeutics, Inc.
STML
$9.88M 0.09%
633,497
– –
RIGL icon
54
Rigel Pharmaceuticals
RIGL
$701M
$9.77M 0.08%
2,518,882
– –
CBIO
55
Crescent Biopharma, Inc. Common Stock
CBIO
$186M
$9.46M 0.08%
563,312
– –
QURE icon
56
uniQure
QURE
$933M
$9.45M 0.08%
+482,557
New +$9.45M
ITCI
57
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$8.82M 0.08%
609,166
– –
ACHN
58
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$8.23M 0.07%
2,856,637
+1,000,000
+54% +$2.88M
ALKS icon
59
Alkermes
ALKS
$5.08B
$8.22M 0.07%
150,251
– –
LUMO
60
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$8.17M 0.07%
1,007,273
– –
AGIO icon
61
Agios Pharmaceuticals
AGIO
$2.36B
$7.36M 0.06%
128,666
– –
CFRX
62
DELISTED
ContraFect Corporation
CFRX
$7.23M 0.06%
7,153,076
– –
XLRN
63
DELISTED
Acceleron Pharma Inc.
XLRN
$6.96M 0.06%
163,900
– –
MGNX icon
64
MacroGenics
MGNX
$121M
$6.91M 0.06%
363,676
– –
VNDA icon
65
Vanda Pharmaceuticals
VNDA
$282M
$6.44M 0.06%
423,884
– –
SYRE icon
66
Spyre Therapeutics
SYRE
$1.03B
$6.16M 0.05%
1,137,872
– –
TTPH
67
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$5.89M 0.05%
935,000
– –
ADMS
68
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$5.85M 0.05%
172,630
– –
NBRV
69
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$5.61M 0.05%
938,235
– –
SYRS
70
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$5.59M 0.05%
574,835
– –
ALBO
71
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$5.12M 0.04%
200,000
– –
FSTX
72
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$5.02M 0.04%
373,144
– –
LJPC
73
DELISTED
La Jolla Pharmaceutical Company
LJPC
$4.98M 0.04%
154,675
– –
GNMX
74
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
$4.87M 0.04%
4,055,142
-491,284
-11% -$590K
CMTA
75
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$4.75M 0.04%
250,000
– –
1 2
3
4 5